ALLMedicine™ Migraine Center

Jun 26th, 2022 - The authors present data on cardiovascular safety for the new acute and preventive migraine treatments including ditans, gepants, and calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) alongside older medications like triptans and e...

Jun 25th, 2022 - Migraine is a common neurological disorder with a higher prevalence occurring in women. Migraine without aura (MwoA) is the most common type of migraine. In recent years, the safety and effectiveness of acupuncture for migraines have been internat...

Jun 25th, 2022 - To report outcomes of patients presenting to the emergency department (ED) with new-onset visual flashes and/or floaters following implementation of a formalized triage protocol allowing eligible patients to be discharged for prompt outpatient oph...

Jun 25th, 2022 - To evaluate the efficacy and safety of concurrent non-invasive stimulation of occipital and trigeminal nerves in acute treatment of migraine with or without aura. Non-invasive neuromodulation devices stimulating a single peripheral nerve or anatom...

Jun 25th, 2022 - Some migraine treatments are contraindicated for patients with cardiovascular disease (CVD) or risk factors (CVRFs). We report safety and efficacy of lasmiditan, a new oral acute migraine treatment with no cardiovascular contraindication, in Japan...

Jul 30th, 2020 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Contro...

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Mar 27th, 2020 - While transcranial magnetic stimulation (TMS) has been studied for the treatment of psychiatric disorders, emerging evidence supports its use for pain and headache by stimulating either motor cortex (M1) or dorsolateral prefrontal cortex (DLPFC). ...

Dec 10th, 2019 - Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.|2019|Szperka CL,VanderPluym JH,Oakley CB,|prevention & control,

May 23rd, 2019 - The Aids to Management are a product of the Global Campaign against Headache, a worldwide programme of action conducted in official relations with the World Health Organization. Developed in partnership with the European Headache Federation, they ...

Jun 24th, 2022 - Small vessel diseases are conditions characterized by the narrowing of small arteries leading to an imbalance of blood supply upon demand. This results in a progressive chronic hypoperfusion with detrimental outcomes for the affected organ system ...

Jun 24th, 2022 - Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in chil...

Jun 24th, 2022 - Objective: The chief goal of this study is to identify the endophenotypes of the spectrum of mood disorders using the methods of genetic epidemiology, developmental psychopathology and clinical psychiatry/psychology. The major research questions f...

Jun 24th, 2022 - Tension-type headache (TTH) is a common type of headache. Its incidence in women has been reported as 18%. It is thought to be associated with stress, contractions in peripheral muscles, and changes in pain transmission and inhibition mechanisms i...

Jun 24th, 2022 - Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in chil...

Jun 23rd, 2022 - A new tool can help streamline diagnosis and treatment of migraine in the primary care setting, new research suggests. Early results from a small pilot study showed that the tool, essentially a medical record "best-practice alert," reduces special...

Jun 23rd, 2022 - Atogepant, a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist approved last year for migraine, is superior to placebo not only in terms of a 50% or greater responder rate but also for a 75% or greater and 100% responder ra...

Jun 23rd, 2022 - DENVER – In line with recommendations, emergency departments dramatically reduced their use of opioids as treatments for headache over a recent 11-year period, a new study finds. But the use of diphenhydramine (Benadryl) more than doubled even tho...

Jun 22nd, 2022 - It's well understood that physicians have limited time to treat patients with stroke before the disease progresses and outcomes can worsen. This case illustrates how differing opinions by remote and in-person physicians — followed by system breakd...

Jun 20th, 2022 - DENVER – More than a weight-loss operation, bariatric surgery can also relieve migraine, possibly because of links between head pain and the gut, a neurologist told colleagues at the annual meeting of the American Headache Society. “There’s eviden.